This manuscript investigates the global biopharmaceutical industrial landscape and development patterns, combining analytical insights into the characteristics of world-class life and health innovation hubs. The study aims to accelerate breakthroughs in critical life sciences technologies, establish an industry-collaborative innovation system, and deepen the convergence of innovation, industrial, financial, and talent chains. Ultimately, it seeks to expedite the creation of top-tier innovation hubs that leverage high-level scientific advancements to spearhead quality development and forge future-oriented competitive advantages. This approach charts a distinctive pathway for life sciences innovation that aligns with international standards, embodies Chinese characteristics, and addresses public health needs through science-driven solutions.